Clinical Trial Update: Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update of TRC105 in combination with abiraterone or enzalutamide in prostate cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Enzalutamide (enzalutamide)
• TRC105 (carotuximab)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-12-30